Based on phenotypic, omics and molecular evidences, we proved that a characteristic marker of CAFs, S100A4, interacts with CLDN18.2 to accelerate the metastatic progression of gastric cancer in a CAF-dependent manner. Here, S100A4 is linked to gastric cancer.